Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Direxion Daily FTSE China Bull 3x Shares trades at $24.61 (market cap $574.76M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 8.2× Direxion Daily FTSE China Bull 3x Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Direxion Daily FTSE China Bull 3x Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Direxion Daily FTSE China Bull 3x Shares for 25 Days on average.
| DFTX | YINN | |
|---|---|---|
Market Cap | $4.71B | $574.76M |
Volume | 1,966,636 | 1,122,984 |
Sector | Health | Leveraged / Inverse |
52-Week High | $48.45 | $52.69 |
52-Week Low | $10.68 | $21.45 |
Typical Hold Time | 0 Days | 25 Days |
Enterprise Value | $3.67B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YINN is trading at $23.56, down 2.97% with a bearish technical outlook. Moving averages signal strong selling pressure while oscillators remain neutral. The stock faces resistance at $24 with support at $23. Recent news highlights China's economic policies affecting Asian markets, though YINN's specific financial metrics are unavailable in the current dataset.
The technical setup suggests continued near-term pressure with key resistance at $24. Investment opportunities depend on China's economic recovery trajectory, while risks include regulatory controls and regional market volatility. The absence of current fundamental data requires careful due diligence before considering position entry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Direxion Daily FTSE China Bull 3x Shares
YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →
